2,021
Views
2
CrossRef citations to date
0
Altmetric
Special Issue on COVID-19

The Impact of Major Events on Ongoing Noninferiority Trials, With Application to COVID-19

&
Pages 443-450 | Received 27 Apr 2020, Accepted 24 Jun 2020, Published online: 05 Aug 2020

References

  • Bartlett, J. W. (2018), “Covariate Adjustment and Estimation of Mean Response in Randomised Trials,” Pharmaceutical Statistics, 17, 648–666.
  • Breslow, N. E., and Clayton, D. G. (1993), “Approximate Inference in Generalized Linear Mixed Models,” Journal of the American Statistical Association, 88, 9–25. DOI: 10.1080/01621459.1993.10594284.
  • Fairclough, D. (2002), Design and Analysis of Quality of Life Studies in Clinical Trials, Boca Raton, FL: Chapman & Hall/CRC Press.
  • Food and Drug Administration (2016), Non-Inferiority Clinical Trials to Establish Effectiveness, Washington, DC: Food and Drug Administration.
  • Ge, M., Durham, L. K., Meyer, R. D., Xie, W., and Thomas, N. (2011), “Covariate-Adjusted Difference in Proportions From Clinical Trials Using Logistic Regression and Weighted Risk Differences,” Drug Information Journal, 45, 481–493. DOI: 10.1177/009286151104500409.
  • International Conference on Harmonisation (1998), Statistical Principles for Clinical Trials E9, London: International Conference on Harmonisation.
  • International Conference on Harmonisation (2019), Addendum on Estimands and Sensitivity Analyses in Clinical Trials E9(R1), London: International Conference on Harmonisation.
  • Molenberghs, G., and Kenward, M. G. (2007), Missing Data in Clinical Studies, Chichester: Wiley.
  • Lipkovich, I., Duan, Y., and Ahmed, S. (2005), “Multiple Imputation Compared With Restricted Pseudo-likelihood and Generalized Estimating Equations for Analysis of Binary Repeated Measures in Clinical Studies,” Pharmaceutical Statistics, 4, 267–285. DOI: 10.1002/pst.188.
  • Lipkovich, I., and Wiens, B. L. (2018), “The Role of Multiple Imputation in Noninferiority Trials for Binary Outcomes,” Statistics in Biopharmaceutical Research, 10, 57–69. DOI: 10.1080/19466315.2017.1379433.
  • Little, R. J., D’Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A. and Neaton, J. D. (2012), “The Prevention and Treatment of Missing Data in Clinical Trials,” New England Journal of Medicine, 367, 1355–1360. DOI: 10.1056/NEJMsr1203730.
  • Mallinckrodt, C., and Lipkovich, I. (2016), Analyzing Longitudinal Clinical Trial Data: A Practical Guide, Boca Raton, FL: Chapman & Hall/CRC Press.
  • Mallinckrodt, C., Molenberghs, G., Lipkovich, I., and Ratitch, B. (2020), Estimands, Estimators and Sensitivity Analysis in Clinical Trials, Chapman & Hall/CRC Biostatistics Series, Boca Raton, FL: Chapman & Hall/CRC Press.
  • Meyer, R. D., Ratitch, B., Wolbers, M., Marchenko, O., Quan, H., Li, D., Fletcher, C., Li, X., Wright, D., Shentu, Y., and Englert, S. (2020) “Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic,” Statistics in Biopharmaceutical Research (in press).
  • Qu, Y., and Luo, J. (2015), “Estimation of Group Means When Adjusting for Covariates in Generalized Linear Models,” Pharmaceutical Statistics, 14, 56–62. DOI: 10.1002/pst.1658.
  • Rothmann, M. D., Wiens, B. L., and Chan, I. S. F. (2012), Design and Analysis of Non-Inferiority Trials, Boca Raton, FL: Chapman & Hall/CRC Press.
  • Robins, J. M., and Wang, N. (2000), “Inference for Imputation Estimators,” Biometrika, 87, 113–124. DOI: 10.1093/biomet/87.1.113.
  • Rubin, D. B. (1987), Multiple Imputation for Nonresponse in Surveys, New York: Wiley.
  • Schafer, J. L. (1997), Analysis of Incomplete Multivariate Data, New York: Chapman & Hall.
  • Wang, N., and Robins, J. M. (1998), “Large-Sample Theory for Parametric Multiple Imputation Procedures,” Biometrika, 85, 935–948. DOI: 10.1093/biomet/85.4.935.
  • Wellek, S. (2010), Testing Statistical Hypotheses of Equivalence and Noninferiority, Boca Raton, FL: Chapman & Hall/CRC Press.
  • Wiens, B. L., and Rosenkranz, G. K. (2013), “Missing Data in Noninferiority Trials,” Statistics in Biopharmaceutical Research, 5, 383–393. DOI: 10.1080/19466315.2013.847383.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.